Caricamento...
Population Pharmacokinetics of Revefenacin in Patients with Chronic Obstructive Pulmonary Disease
BACKGROUND AND OBJECTIVES: Revefenacin is a lung-selective, long-acting muscarinic antagonist indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease. The objectives of this analysis were to evaluate the pharmacokinetics of revefenacin and its major metabolite...
Salvato in:
| Pubblicato in: | Clin Pharmacokinet |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer International Publishing
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7932972/ https://ncbi.nlm.nih.gov/pubmed/33124005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-020-00938-3 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|